Small folate-based molecules are excreted too quickly by the kidneys before reaching therapeutic levels at tumor sites. Extending blood circulation time increases the probability of target binding and improves diagnostic signal-to-noise ratios.

Presence of unwanted isomers in folate tracers reduces diagnostic accuracy and binding affinity. Achieving isomeric purity ensures precise targeting and higher signal-to-noise ratios in imaging.